SV Atlas
← All founders
Wesley Wierson

3x founder

Wesley Wierson

Genome Hacker | Founder and CEO | Accelerating CAR-T Cell Therapy Through Intelligent Design

Co-founderLEAH Labs logoLEAH Labs· Winter 2019Greater Minneapolis-St. Paul Area
2026Co-founder· VelociTx Inc.
Founder · since 2018
Company
VelociTx Inc.
Role
Co-Founder and CEO
current
Stage
—
no public source
Raised
—
no public source
Based
Minneapolis, MN
current
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
LEAH Labs logo
LEAH Labs

Living therapies for pets first, and their people next

Winter 2019

Experience

Career

  • LEAH Laboratories logo

    LEAH Laboratories

    Founder

    Founder and CEO · Eagan, Minnesota, United States · 2018 – Present

    2018
  • VelociTx Inc. logo

    VelociTx Inc.

    Co-founder

    Co-Founder and CEO · Minneapolis, MN · 2026 – Present

    2026
  • Lifengine Technologies logo

    Lifengine Technologies

    Venture Engineer · Rochester, Minnesota · 2018 – Present

    2018
  • UViiVE Inc. logo

    UViiVE Inc.

    Co-founder

    Co-Founder · Greater Minneapolis-St. Paul Area · 2025 – Present

    2025
  • Lifengine Technologies logo

    Lifengine Technologies

    Venture Engineer · Rochester, Minnesota · 2018 – Present

    2018
  • Iowa State University logo

    Iowa State University

    Doctor of Philosophy · Ames, Iowa · 2014 – 2018

    2014
  • DuPont Pioneer

    Plant Transformation/Molecular Biology Intern · Johnston, Iowa · 2013 – 2014

    2013
  • Iowa State University logo

    Iowa State University

    Undergraduate Research Assistant · Iowa State University · 2011 – 2013

    2011

Bio

I am a scientist and entrepreneur applying my expertise in gene editing towards solving consumer level problems in society, first focused on building curative cancer therapies for pets, and eventually their owners. Through my time at LEAH Labs, I've also found a passion for biotech business model innovation through regulatory arbitrage - e.g. CAR-T in pets is regulated by USDA, not FDA, thus we can get to market 2-3x faster and for 500x less capital than human CAR-T